Related Experiment Video
Updated: Apr 9, 2026

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
Long-Term Efficacy and Outcomes of Endovascular Interventions in Budd-Chiari Syndrome-A Real World Analysis
Amar Mukund1, Vaibhav Thakur1, Ankur Jindal1
1Institute of Liver and Biliary Sciences, New Delhi, India.
Insights
Endovascular interventions like hepatic vein recanalization and Direct Intrahepatic Portosystemic Shunt (DIPS) effectively manage Budd-Chiari Syndrome (BCS). Hepatic vein recanalization offers superior long-term patency and fewer repeat procedures compared to DIPS.
Area of Science:
- Interventional Radiology
- Hepatology
- Vascular Surgery
Background:
- Budd-Chiari Syndrome (BCS) is a rare condition characterized by hepatic venous outflow obstruction.
- Endovascular interventions are crucial for managing BCS, aiming to restore liver blood flow and improve patient outcomes.
- Evaluating the long-term efficacy and safety of different endovascular techniques is essential for optimizing BCS treatment strategies.
Purpose of the Study:
- To assess the long-term safety, efficacy, and clinical outcomes of endovascular interventions in Budd-Chiari Syndrome (BCS) patients.
- To compare the outcomes of hepatic vein/inferior vena cava recanalization with Direct Intrahepatic Portosystemic Shunt (DIPS) procedures.
- To determine the patency rates and survival outcomes associated with these endovascular approaches in BCS.
Main Methods:
- Retrospective analysis of electronic medical records for BCS patients undergoing endovascular interventions from 2010 to 2022.
- Inclusion criteria required at least two years of follow-up.
- Analysis of laboratory parameters, clinical outcomes (ascites, rebleeding), intervention types, patency rates, and survival rates.
Main Results:
- 161 BCS patients underwent endovascular interventions: 103 with hepatic vein/inferior vena cava recanalization and 58 with DIPS.
- Both interventions significantly improved clinical outcomes and ALBI grades (p < 0.01).
- Hepatic vein recanalization showed higher patency rates (96% at 1 year, 92% at 5 years) and required fewer repeat interventions (7.7%) compared to DIPS (82% and 45% patency, 58.6% repeat interventions). 10-year survival was 92% for recanalization and 88% for DIPS.
Conclusions:
- Endovascular interventions are effective in resolving symptoms and providing excellent long-term survival for BCS patients.
- Hepatic vein/inferior vena cava recanalization demonstrates superior long-term patency and a lower need for repeat procedures compared to DIPS.
- DIPS is associated with higher baseline disease severity scores and a greater requirement for re-intervention, indicating its use in more complex BCS cases.
Purpose:
To evaluate the long-term safety, efficacy, and clinical outcomes of endovascular interventions [hepatic vein/inferior vena cava recanalization and Direct Intrahepatic Portosystemic Shunt (DIPS)] in patients with Budd-Chiari Syndrome (BCS).
Methods:
We retrospectively analysed electronic medical records of consecutive BCS patients who underwent endovascular interventions between 2010 and 2022 with at least 2 years of follow-up. We analysed laboratory and clinical parameters, types of interventions, patency rates, and survival outcomes.
Results:
Of 415 BCS patients, 161 patients underwent endovascular interventions (median age 33.06 (5-75) years, male-to-female ratio 2.2:1). 103 patients who underwent hepatic vein/inferior vena cava recanalization (angioplasty/stenting) and 58 patients who underwent DIPS. The DIPS group had higher baseline median Child-Turcotte-Pugh (CTP) score (8.27), MELD score (14.94) and Rotterdam score (0.96). The recanalization group had baseline CTP score (6.95), MELD score (13.01) and Rotterdam score (0.56). Both interventions resulted in significant improvements in clinical outcomes (ascites resolution and prevention of rebleeding) and ALBI grades (p < 0.01). The DIPS group had persistently higher MELD and ALBI scores (p < 0.05) and required more repeat endovascular interventions (58.6%). The recanalization group required fewer repeat interventions (7.7%). Patency rates at 1 and 5 years were 96% and 92% for recanalization, 82% and 45% for DIPS, and 100% and 60% for DIPS revisions, respectively. The 10-year survival rate was 92% for the recanalization group and 88% for the DIPS group.
Conclusion:
Endovascular interventions provide higher rates of symptom resolution and excellent long-term overall survival in BCS patients. Patients undergoing DIPS exhibited persistently higher severity scores and a higher need for repeat interventions, consistent with a more severe disease phenotype at baseline.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Peripheral Artery Disease III: Interprofessional Care
